ARTIVION, INC. (AORT)
Every FINRA and SEC series the site collects for ARTIVION, INC.: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on NYSE, classified by the SEC as surgical & medical instruments & apparatus.
2.9M
Short interest
settlement 2026-08-31
4.4
Days to cover
+6.6% vs prior
57.8%
Short share of volume
2026-09-17
3,539
Fails to deliver
settlement 2026-08-28
Thu 5 Nov
Next earnings
estimated; last year 2025-11-06
-$2.6M
Insider flow, 90 days
0 buys, 7 sells
As of 2026-09-17.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 31 August 2026, short interest in AORT is 2,927,038 shares, up 221,537 shares over the last month. Over the last 48 readings it ranged from 995,912 shares (15 August 2025) to 4,337,827 shares (15 May 2025). At the reported average volume of 662K shares a day that is 4.4 days to cover.
Embed this chartkeeps the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/aort" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-31 | 2,927,038 | +6.6% | 662,170 | 4.42 |
| 2026-08-14 | 2,745,747 | +1.5% | 857,370 | 3.20 |
| 2026-07-31 | 2,705,501 | +8.3% | 568,148 | 4.76 |
| 2026-07-15 | 2,498,637 | +14.6% | 550,079 | 4.54 |
| 2026-06-30 | 2,179,918 | +15.4% | 1,075,389 | 2.03 |
| 2026-06-15 | 1,888,924 | -1.5% | 810,012 | 2.33 |
| 2026-05-29 | 1,917,337 | -1.3% | 679,115 | 2.82 |
| 2026-05-15 | 1,942,065 | +1.1% | 1,140,219 | 1.70 |
| 2026-04-30 | 1,920,829 | -1.2% | 303,547 | 6.33 |
| 2026-04-15 | 1,943,835 | +16.6% | 523,130 | 3.72 |
| 2026-03-31 | 1,667,100 | -0.4% | 389,108 | 4.28 |
| 2026-03-13 | 1,674,278 | +6.3% | 396,231 | 4.23 |
| 2026-02-27 | 1,575,745 | +13.6% | 568,701 | 2.77 |
| 2026-02-13 | 1,386,551 | -15.4% | 489,962 | 2.83 |
| 2026-01-30 | 1,638,404 | +2.6% | 312,918 | 5.24 |
| 2026-01-15 | 1,596,695 | +12.6% | 291,741 | 5.47 |
| 2025-12-31 | 1,418,454 | +18.9% | 363,950 | 3.90 |
| 2025-12-15 | 1,193,038 | -0.1% | 356,351 | 3.35 |
| 2025-11-28 | 1,194,637 | -5.8% | 336,355 | 3.55 |
| 2025-11-14 | 1,268,743 | -8.1% | 500,639 | 2.53 |
| 2025-10-31 | 1,380,204 | +4.9% | 350,551 | 3.94 |
| 2025-10-15 | 1,315,327 | -2.3% | 271,844 | 4.84 |
| 2025-09-30 | 1,346,234 | +24.1% | 506,460 | 2.66 |
| 2025-09-15 | 1,084,337 | -0.8% | 400,343 | 2.71 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 17 September 2026, the short share of AORT volume is 57.8%, down 17.5 points over the last five sessions. Over the last 52 readings it ranged from 29.0% (3 August 2026) to 83.9% (22 July 2026). The latest reading is 3.1 points above the 30-session average of 54.7%, on 220K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-17 | 127K | 220K | 57.8% | 0 |
| 2026-09-16 | 126K | 236K | 53.4% | 46 |
| 2026-09-15 | 191K | 438K | 43.5% | 0 |
| 2026-09-14 | 97K | 229K | 42.5% | 0 |
| 2026-09-11 | 102K | 188K | 54.5% | 0 |
| 2026-09-10 | 122K | 162K | 75.2% | 0 |
| 2026-09-09 | 122K | 195K | 62.7% | 0 |
| 2026-09-08 | 173K | 269K | 64.6% | 0 |
| 2026-09-04 | 89K | 142K | 63.0% | 6,794 |
| 2026-09-03 | 89K | 148K | 60.0% | 5 |
| 2026-09-02 | 95K | 145K | 65.1% | 0 |
| 2026-09-01 | 167K | 261K | 64.1% | 0 |
| 2026-08-31 | 119K | 263K | 45.2% | 0 |
| 2026-08-28 | 89K | 183K | 48.8% | 0 |
| 2026-08-27 | 89K | 180K | 49.5% | 5 |
| 2026-08-26 | 142K | 280K | 50.8% | 1,653 |
| 2026-08-25 | 165K | 298K | 55.4% | 10 |
| 2026-08-24 | 154K | 293K | 52.6% | 0 |
| 2026-08-21 | 85K | 198K | 43.0% | 0 |
| 2026-08-20 | 187K | 347K | 53.9% | 0 |
| 2026-08-19 | 104K | 261K | 39.7% | 0 |
| 2026-08-18 | 171K | 355K | 48.1% | 0 |
| 2026-08-17 | 117K | 188K | 62.1% | 0 |
| 2026-08-14 | 194K | 373K | 52.1% | 0 |
| 2026-08-13 | 193K | 406K | 47.7% | 0 |
| 2026-08-12 | 236K | 385K | 61.4% | 0 |
| 2026-08-11 | 250K | 411K | 60.7% | 0 |
| 2026-08-10 | 147K | 317K | 46.5% | 0 |
| 2026-08-07 | 265K | 410K | 64.6% | 0 |
| 2026-08-06 | 219K | 415K | 52.7% | 0 |
Fails to deliver
SEC, by settlement date. JSONAs of 28 August 2026, the fails-to-deliver balance in AORT is 3,539 shares, up 3,505 shares over the last settlement date. Over the last 52 readings it ranged from 2 shares (28 May 2025) to 85,352 shares (20 February 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-28 | 3,539 | $26.67 | $94K |
| 2026-08-26 | 34 | $26.38 | $897 |
| 2026-08-20 | 165 | $28.82 | $5K |
| 2026-08-19 | 409 | $28.90 | $12K |
| 2026-08-14 | 153 | $28.41 | $4K |
| 2026-08-03 | 2 | $26.83 | $54 |
| 2026-07-22 | 203 | $24.94 | $5K |
| 2026-07-01 | 186 | $22.47 | $4K |
| 2026-06-26 | 3 | $22.66 | $68 |
| 2026-06-18 | 70 | $21.20 | $1K |
| 2026-06-16 | 6 | $21.07 | $126 |
| 2026-06-15 | 1,649 | $20.10 | $33K |
| 2026-06-12 | 182 | $20.60 | $4K |
| 2026-06-02 | 355 | $21.05 | $7K |
| 2026-05-19 | 170 | $23.76 | $4K |
| 2026-04-08 | 121 | $35.22 | $4K |
| 2026-03-25 | 2,665 | $35.70 | $95K |
| 2026-03-23 | 8 | $35.31 | $282 |
| 2026-03-17 | 16,174 | $37.40 | $605K |
| 2026-03-06 | 27 | $37.86 | $1K |
| 2026-02-20 | 85,352 | $38.00 | $3.2M |
| 2026-01-05 | 40 | $44.46 | $2K |
| 2025-12-26 | 195 | $46.89 | $9K |
| 2025-12-04 | 15,315 | $45.48 | $697K |
| 2025-11-17 | 2,941 | $45.70 | $134K |
| 2025-11-14 | 2,942 | $45.59 | $134K |
| 2025-10-30 | 732 | $44.99 | $33K |
| 2025-10-24 | 24 | $43.40 | $1K |
| 2025-10-14 | 1,783 | $40.63 | $72K |
| 2025-09-22 | 1,698 | $40.55 | $69K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at AORT reported 7 open-market sells worth $2.6M in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: GREEN ANDREW M (SVP, Regulatory and Quality) on 2026-09-10.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-10 | GREEN ANDREW M | SVP, Regulatory and Quality | Sell | 11K | $24.97 | $287K | 40K |
| 2026-09-03 | GREEN ANDREW M | SVP, Regulatory and Quality | Sell | 1K | $26.02 | $39K | 52K |
| 2026-09-02 | GREEN ANDREW M | SVP, Regulatory and Quality | Sell | 7K | $27.27 | $177K | 53K |
| 2026-08-19 | Mackin James P | President & CEO | Sell | 70K | $28.95 | $2.0M | 877K |
| 2026-08-14 | GREEN ANDREW M | SVP, Regulatory and Quality | Sell | 616 | $28.55 | $18K | 60K |
| 2026-08-14 | Berry Lance A | EVP, COO, CFO & Treasurer | Sell | 715 | $28.55 | $20K | 210K |
| 2026-08-12 | Holloway Jean F | SVP, General Counsel | Sell | 977 | $28.49 | $28K | 184K |
| 2026-06-11 | GREEN ANDREW M | SVP, Regulatory and Quality | Sell | 30K | $20.69 | $621K | 60K |
| 2026-06-11 | GREEN ANDREW M | SVP, Regulatory and Quality | Option exercise | 30K | $11.03 | $331K | 90K |
| 2026-06-11 | GREEN ANDREW M | SVP, Regulatory and Quality | Sell | 14K | $20.71 | $290K | 60K |
| 2026-06-11 | GREEN ANDREW M | SVP, Regulatory and Quality | Option exercise | 14K | $18.44 | $258K | 74K |
| 2026-06-02 | SEMEDO ANTHONY B. | n/a | J | 6K | $0.00 | $0 | 41K |
| 2026-05-18 | Borgstrom Marna P | Director | Grant | 8K | $0.00 | $0 | 57K |
| 2026-05-18 | SEMEDO ANTHONY B. | n/a | Grant | 8K | $0.00 | $0 | 47K |
| 2026-05-18 | Salveson Jon W | n/a | Grant | 8K | $0.00 | $0 | 137K |
| 2026-05-18 | Hoff Elizabeth A | n/a | Grant | 8K | $0.00 | $0 | 35K |
| 2026-05-18 | Burbank Jeffrey H | n/a | Grant | 8K | $0.00 | $0 | 61K |
| 2026-05-18 | Bullock James | n/a | Grant | 8K | $0.00 | $0 | 76K |
| 2026-05-18 | BEVEVINO DANIEL J | n/a | Grant | 8K | $0.00 | $0 | 158K |
| 2026-05-18 | ACKERMAN THOMAS F | n/a | Grant | 8K | $0.00 | $0 | 157K |
| 2026-05-14 | Borgstrom Marna P | n/a | Grant | 8K | $0.00 | $0 | 57K |
| 2026-03-04 | Holloway Jean F | SVP, General Counsel | Sell | 9K | $38.00 | $341K | 185K |
| 2026-03-03 | Horton Amy | VP, Chief Accounting Officer | Sell | 901 | $37.78 | $34K | 139K |
| 2026-03-03 | Holloway Jean F | SVP, General Counsel | Sell | 4K | $37.78 | $145K | 194K |
| 2026-03-03 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 2K | $37.78 | $81K | 60K |
| 2026-03-03 | Davis John E | Chief Commercial Officer | Sell | 5K | $37.78 | $173K | 231K |
| 2026-03-03 | Berry Lance A | EVP, COO, CFO & Treasurer | Sell | 6K | $37.78 | $239K | 211K |
| 2026-03-03 | Mackin James P | President & CEO | Sell | 18K | $37.78 | $676K | 947K |
| 2026-03-02 | Horton Amy | VP, Chief Accounting Officer | Sell | 641 | $38.02 | $24K | 133K |
| 2026-03-02 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 2K | $38.02 | $58K | 40K |
| 2026-03-02 | Mackin James P | President & CEO | Sell | 15K | $38.02 | $567K | 848K |
| 2026-03-02 | Holloway Jean F | SVP, General Counsel | Sell | 2K | $38.02 | $83K | 170K |
| 2026-03-02 | Berry Lance A | EVP, COO, CFO & Treasurer | Sell | 5K | $38.02 | $197K | 176K |
| 2026-03-02 | Davis John E | Chief Commercial Officer | Sell | 3K | $38.02 | $106K | 207K |
| 2026-03-02 | Horton Amy | VP, Chief Accounting Officer | Grant | 7K | $0.00 | $0 | 140K |
| 2026-03-02 | Holloway Jean F | SVP, General Counsel | Grant | 28K | $0.00 | $0 | 198K |
| 2026-03-02 | Stanton Marshall S. | SVP, Clinical & MD Affair | Grant | 22K | $0.00 | $0 | 62K |
| 2026-03-02 | Davis John E | Chief Commercial Officer | Grant | 29K | $0.00 | $0 | 235K |
| 2026-03-02 | Berry Lance A | EVP, COO, CFO & Treasurer | Grant | 41K | $0.00 | $0 | 217K |
| 2026-03-02 | Mackin James P | President & CEO | Grant | 117K | $0.00 | $0 | 965K |
| 2026-02-24 | Horton Amy | VP, Chief Accounting Officer | Grant | 6K | $0.00 | $0 | 133K |
| 2026-02-24 | Horton Amy | VP, Chief Accounting Officer | Sell | 830 | $35.69 | $30K | 127K |
| 2026-02-24 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 1K | $35.69 | $45K | 42K |
| 2026-02-24 | Holloway Jean F | SVP, General Counsel | Grant | 20K | $0.00 | $0 | 172K |
| 2026-02-24 | Holloway Jean F | SVP, General Counsel | Sell | 2K | $35.69 | $60K | 152K |
| 2026-02-24 | Mackin James P | President & CEO | Grant | 97K | $0.00 | $0 | 863K |
| 2026-02-24 | Mackin James P | President & CEO | Sell | 14K | $35.69 | $497K | 766K |
| 2026-02-24 | Berry Lance A | EVP, COO, CFO & Treasurer | Grant | 37K | $0.00 | $0 | 181K |
| 2026-02-24 | Berry Lance A | EVP, COO, CFO & Treasurer | Sell | 4K | $35.69 | $160K | 144K |
| 2026-02-24 | Davis John E | Chief Commercial Officer | Grant | 20K | $0.00 | $0 | 209K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Planned sales (Form 144)
Newest first. JSON50 Form 144 notices on file for AORT worth $18.9M at the prices reported; 7 in the last 90 days worth $2.8M. Latest: GREEN ANDREW M filed on 2026-09-10 to sell 11,480 shares ($287K) from 2026-09-10.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-10 | GREEN ANDREW MOfficer | 11K | $287K | 0.024% | 2026-09-10 | Fidelity Brokerage Services LLC |
| 2026-09-03 | GREEN ANDREW MOfficer | 1K | $39K | 0.003% | 2026-09-03 | Fidelity Brokerage Services LLC |
| 2026-09-02 | GREEN ANDREW MOfficer | 7K | $177K | 0.013% | 2026-09-02 | Fidelity Brokerage Services LLC |
| 2026-08-27 | Stanton Marshall S.Officer | 7K | $199K | 0.015% | 2026-08-27 | Fidelity Brokerage Services LLC |
| 2026-08-19 | Mackin James POfficer | 70K | $2.1M | 0.144% | 2026-08-19 | Fidelity Investments |
| 2026-08-14 | Berry Lance AOfficer | 715 | $20K | 0.001% | 2026-08-14 | Fidelity Brokerage Services LLC |
| 2026-08-14 | GREEN ANDREW MOfficer | 616 | $18K | 0.001% | 2026-08-14 | Fidelity Brokerage Services LLC |
| 2026-06-11 | GREEN ANDREW MOfficer | 44K | $911K | 0.091% | 2026-06-11 | Fidelity Brokerage Services LLC |
| 2026-03-04 | JEAN F HOLLOWAYOfficer | 9K | $341K | 0.019% | 2026-03-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-03 | Berry Lance AOfficer | 6K | $239K | 0.013% | 2026-03-03 | Fidelity Brokerage Services LLC |
| 2026-03-03 | Davis John EOfficer | 5K | $173K | 0.010% | 2026-03-03 | Fidelity Brokerage Services LLC |
| 2026-03-03 | Holloway Jean FOfficer | 4K | $145K | 0.008% | 2026-03-03 | Fidelity Brokerage Services LLC |
| 2026-03-03 | Stanton Marshall S.Officer | 2K | $81K | 0.004% | 2026-03-03 | Fidelity Brokerage Services LLC |
| 2026-03-03 | Mackin James POfficer, Director | 18K | $676K | 0.037% | 2026-03-03 | Fidelity Brokerage Services LLC |
| 2026-03-03 | Horton AmyOfficer | 901 | $34K | 0.002% | 2026-03-03 | Fidelity Brokerage Services LLC |
| 2026-03-02 | Holloway Jean FOfficer | 2K | $83K | 0.005% | 2026-03-02 | Fidelity Brokerage Services LLC |
| 2026-03-02 | Mackin James POfficer, Director | 15K | $567K | 0.031% | 2026-03-02 | Fidelity Brokerage Services LLC |
| 2026-03-02 | Davis John EOfficer | 3K | $106K | 0.006% | 2026-03-02 | Fidelity Brokerage Services LLC |
| 2026-03-02 | Horton AmyOfficer | 641 | $24K | 0.001% | 2026-03-02 | Fidelity Brokerage Services LLC |
| 2026-03-02 | Berry Lance AOfficer | 5K | $197K | 0.011% | 2026-03-02 | Fidelity Brokerage Services LLC |
| 2026-03-02 | Stanton Marshall S.Officer | 2K | $58K | 0.003% | 2026-03-02 | Fidelity Brokerage Services LLC |
| 2026-02-24 | Davis John EOfficer | 2K | $74K | 0.004% | 2026-02-24 | Fidelity Brokerage Services LLC |
| 2026-02-24 | Berry Lance AOfficer | 4K | $160K | 0.009% | 2026-02-24 | Fidelity Brokerage Services LLC |
| 2026-02-24 | Holloway Jean FOfficer | 2K | $60K | 0.003% | 2026-02-24 | Fidelity Brokerage Services LLC |
| 2026-02-24 | Mackin James POfficer, Director | 14K | $497K | 0.029% | 2026-02-24 | Fidelity Brokerage Services LLC |
| 2026-02-24 | Stanton Marshall S.Officer | 1K | $45K | 0.003% | 2026-02-24 | Fidelity Brokerage Services LLC |
| 2026-02-24 | Horton AmyOfficer | 830 | $30K | 0.002% | 2026-02-24 | Fidelity Brokerage Services LLC |
| 2026-02-23 | Horton AmyOfficer | 2K | $65K | 0.004% | 2026-02-23 | Fidelity Brokerage Services LLC |
| 2026-02-23 | Mackin James POfficer, Director | 21K | $788K | 0.044% | 2026-02-23 | Fidelity Brokerage Services LLC |
| 2026-02-23 | Holloway Jean FOfficer | 3K | $116K | 0.006% | 2026-02-23 | Fidelity Brokerage Services LLC |
| 2026-02-23 | Davis John EOfficer | 4K | $142K | 0.008% | 2026-02-23 | Fidelity Brokerage Services LLC |
| 2026-02-23 | Berry Lance AOfficer | 5K | $187K | 0.010% | 2026-02-23 | Fidelity Brokerage Services LLC |
| 2026-02-23 | Stanton Marshall S.Officer | 2K | $91K | 0.005% | 2026-02-23 | Fidelity Brokerage Services LLC |
| 2025-12-17 | Davis John EOfficer | 5K | $226K | 0.011% | 2025-12-15 | CHARLES SCHWAB |
| 2025-12-08 | Horton AmyOfficer | 5K | $203K | 0.010% | 2025-12-08 | Fidelity Brokerage Services LLC |
| 2025-12-03 | Mackin James POfficer, Director | 31K | $1.4M | 0.065% | 2025-12-03 | Fidelity Brokerage Services LLC |
| 2025-12-03 | JEAN F HOLLOWAYOfficer | 7K | $331K | 0.015% | 2025-12-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-02 | Mackin James POfficer, Director | 31K | $1.4M | 0.065% | 2025-12-02 | Fidelity Brokerage Services LLC |
| 2025-11-21 | Stanton Marshall S.Officer | 47K | $2.1M | 0.100% | 2025-11-21 | Fidelity Brokerage Services LLC |
| 2025-11-20 | Stanton Marshall S.Officer | 15K | $675K | 0.032% | 2025-11-20 | Fidelity Brokerage Services LLC |
| 2025-11-18 | ELIZABETH A HOFFDirector | 4K | $189K | 0.009% | 2025-11-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-17 | Davis John EOfficer | 6K | $289K | 0.013% | 2025-11-17 | Fidelity Brokerage Services LLC |
| 2025-11-17 | Horton AmyOfficer | 6K | $274K | 0.013% | 2025-11-17 | Fidelity Brokerage Services LLC |
| 2025-11-17 | Holloway Jean FOfficer | 6K | $289K | 0.013% | 2025-11-17 | Fidelity Brokerage Services LLC |
| 2025-11-14 | Holloway Jean FOfficer | 6K | $288K | 0.013% | 2025-11-14 | Fidelity Brokerage Services LLC |
| 2025-11-14 | Davis John EOfficer | 6K | $286K | 0.013% | 2025-11-14 | Fidelity Brokerage Services LLC |
| 2025-11-13 | Horton AmyOfficer | 3K | $160K | 0.007% | 2025-11-13 | Fidelity Brokerage Services LLC |
| 2025-11-13 | Holloway Jean FOfficer | 6K | $264K | 0.012% | 2025-11-13 | Fidelity Brokerage Services LLC |
| 2025-11-13 | Mackin James POfficer, Director | 34K | $1.6M | 0.072% | 2025-11-13 | Fidelity Brokerage Services LLC |
| 2025-11-13 | Stanton Marshall S.Officer | 5K | $229K | 0.011% | 2025-11-13 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person, newest filing first. JSON13 holders above 5% have filed on AORT, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 12.7% of the class (5,977,264 shares), filed 2025-10-17 for an event on 2025-09-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 1 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC.parent holding company | 3.2M | 6.5% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | NOMURA INVESTMENT MANAGEMENT BUSINESS TRUSTinvestment adviser | 3.2M | 6.5% | 2026-06-30 |
| 2026-08-06 | 13G/Ano. 2 | FMR LLCparent holding company | 2.0M | 4.0% | 2026-06-30 |
| 2026-08-06 | 13G/Ano. 2 | Abigail P. Johnsonindividual | 2.0M | 4.0% | 2026-06-30 |
| 2026-03-26 | 13G/Ano. 6 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-17 | 13G | NOMURA INVESTMENT MANAGEMENT BUSINESS TRUSTinvestment adviser | 2.6M | 5.5% | 2025-12-31 |
| 2026-02-17 | 13G | NOMURA ASSET MANAGEMENT INTERNATIONAL INC.parent holding company | 2.6M | 5.5% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 7 | Macquarie Management Holdings Incparent holding company | 0 | 0.0% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 7 | Macquarie Investment Management Business Trustinvestment adviser | 0 | 0.0% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 7 | Macquarie Group Limitedparent holding company | 0 | 0.0% | 2025-12-31 |
| 2025-11-14 | 13G/Ano. 1 | Perceptive Advisors LLCinvestment adviser | 2.0M | 4.3% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 1 | Joseph Edelmanindividual | 2.0M | 4.3% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 1 | Perceptive Life Sciences Master Fund, Ltd.corporation | 2.0M | 4.3% | 2025-09-30 |
| 2025-11-13 | 13G/Ano. 6 | Macquarie Group Limitedparent holding company | 2.5M | 5.3% | 2025-09-30 |
| 2025-11-13 | 13G/Ano. 6 | Macquarie Investment Management Business Trustinvestment adviser | 2.5M | 5.3% | 2025-09-30 |
| 2025-11-13 | 13G/Ano. 6 | Macquarie Management Holdings Incparent holding company | 2.5M | 5.3% | 2025-09-30 |
| 2025-11-07 | 13G/Ano. 2 | Morgan Stanleyparent holding company, corporation | 2.1M | 4.4% | 2025-09-30 |
| 2025-10-17 | 13G/Ano. 5 | BlackRock, Inc.parent holding company | 6.0M | 12.7% | 2025-09-30 |
13F holders
Tracked managers holding AORT at their latest 13F. JSON5 of the 30 tracked managers held AORT at their latest 13F, $39.0M in total at quarter-end prices. Citadel Advisors is the largest at $18.6M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 828K | $18.6M | 0.00% | +757K |
| D. E. Shaw & Co. | 2026-06-30 | 438K | $9.8M | 0.00% | +432K |
| Two Sigma Investments | 2026-06-30 | 387K | $8.7M | 0.01% | -339K |
| Renaissance Technologies | 2026-06-30 | 68K | $1.5M | 0.00% | new or n/a |
| AQR Capital Management | 2026-06-30 | 14K | $323K | 0.00% | -4K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 2026 (quarter ended 2026-06-30) ARTIVION, INC. reported revenue of $125.8M, up 11.3% from the same quarter a year earlier, and net loss of $13.5M (-0.28 diluted EPS). In FY 2025 it generated $39.9M of operating cash flow. As of 2026-06-30, cash was $77.3M against $363.4M of debt.
- Cash
- $77.3M
- Debt
- $363.4M
- Equity
- $445.6M
- Total assets
- $1.07B
- Shares outstanding
- 48,756,221
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $125.8M | -$13.5M | -10.7% | -0.28 |
| Q1 2026 | 2026-03-31 | $116.3M | $1.4M | 1.2% | 0.03 |
| Q4 2025derived | 2025-12-31 | $116.0M | $2.4M | 2.1% | n/a |
| Q3 2025 | 2025-09-30 | $113.4M | $6.5M | 5.7% | 0.13 |
| Q2 2025 | 2025-06-30 | $113.0M | $1.3M | 1.2% | 0.03 |
| Q1 2025 | 2025-03-31 | $99.0M | -$505K | -0.5% | -0.01 |
| Q4 2024derived | 2024-12-31 | $97.3M | -$16.5M | -16.9% | n/a |
| Q3 2024 | 2024-09-30 | $95.8M | -$2.3M | -2.4% | -0.05 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $441.3M | $9.8M | $39.9M | $39.0M | n/a | n/a |
| FY 2024 | 2024-12-31 | $388.5M | -$13.4M | $22.2M | $11.2M | n/a | n/a |
| FY 2023 | 2023-12-31 | $354.0M | -$30.7M | $18.8M | $9.8M | n/a | n/a |
| FY 2022 | 2022-12-31 | $313.8M | -$19.2M | -$5.2M | $10.7M | n/a | n/a |
| FY 2021 | 2021-12-31 | $298.8M | -$14.8M | -$2.6M | $13.1M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-31 from the cover page.
What this page is
ARTIVION, INC. in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows ARTIVION, INC. (AORT), SEC CIK 784199, listed on NYSE, classified by the SEC as surgical & medical instruments & apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-31.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-17.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-28.JSON and CSV
- Planned sales
- SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-09-10.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K Item 2.02 (full-text search)EDGAR full-text search read twice a day; the estimate is last year's date plus 52 weeks. Latest 2026-08-06.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-09-10.JSON and CSV
- Company record
- EDGAR filing index for CIK 784199Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 18 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as surgical & medical instruments & apparatus
- BSXBOSTON SCIENTIFIC CORP
- TNDMTANDEM DIABETES CARE INC
- DXCMDEXCOM INC
- PENPenumbra Inc
- SIBNSI-BONE, Inc.
- MMM3M CO
- LMATLEMAITRE VASCULAR INC
- INSPInspire Medical Systems, Inc.
- NVCRNovoCure Ltd
- RMDRESMED INC
- SYKSTRYKER CORP
- GKOSGLAUKOS Corp
- IRTCiRhythm Holdings, Inc.
- ICUIICU MEDICAL INC/DE
- ATECAlphatec Holdings, Inc.
- PODDINSULET CORP
- BDXBECTON DICKINSON & CO
- IRMDIRADIMED CORP
- ATRCAtriCure, Inc.
- UFPTUFP TECHNOLOGIES INC
- LUNGPulmonx Corp
- MMSIMERIT MEDICAL SYSTEMS INC
- ANGOANGIODYNAMICS INC
- OFIXOrthofix Medical Inc.
Datasets
Frequently Asked Questions
How much of AORT is sold short?
What is AORT's daily short volume?
Does AORT have fails to deliver?
Are AORT insiders buying or selling?
Have AORT insiders filed to sell?
Who owns more than 5% of AORT?
What did AORT report last quarter?
Which funds hold AORT?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.